Arcutis Biotherapeutics (ARQT) Stock Research

Thursday

Arcutis Biotherapeutics price target raised by $4 at Morgan Stanley

ARQT

Aug 6, 7:34 AM

Arcutis Biotherapeutics price target raised by $1 at Mizuho

ARQT

Aug 6, 7:14 AM

Arcutis Biotherapeutics price target raised by $3 at Guggenheim, here's why

ARQT

Aug 6, 6:42 AM

Wednesday

Arcutis Biotherapeutics raises FY26 revenue view to $525M-$540M from $480M-$495M

ARQT

Aug 5, 4:16 PM

Arcutis Biotherapeutics reports Q2 EPS 11c, consensus 5c

ARQT

Aug 5, 4:15 PM

Over a week ago

Arcutis appoints Mirum Pharmaceuticals CEO Christopher Peetz to board

Jul 16, 9:11 AM

Arcutis Biotherapeutics announces FDA acceptance of Zoryve sNDA

ARQT

Jul 8, 8:13 AM

FDA approves supplemental NDA to expand indication of Arcutis' Zoryve cream

ARQT

Jun 29, 7:27 PM

Arcutis Biotherapeutics price target lowered by $1 at Morgan Stanley

ARQT

May 7, 9:11 AM

Arcutis Biotherapeutics backs FY26 revenue view $480M-$495M, consensus $498.07M

ARQT

May 6, 4:26 PM

Arcutis Biotherapeutics reports Q1 EPS (9c), consensus (6c)

ARQT

May 6, 4:25 PM

Arcutis Biotherapeutics submits Zoryve supplemental new drug application

ARQT

Apr 27, 8:42 AM

Arcutis Biotherapeutics presents new Phase 2 results on Zoryve cream

ARQT

Mar 29, 10:27 AM

Arcutis Biotherapeutics to present clinical data on ZORYVE at AAD Meeting

ARQT

Mar 18, 8:18 AM

Arcutis Biotherapeutics announces publication on Phase 3 study of Zoryve cream

ARQT

Mar 10, 9:07 AM

Arcutis announces promotion of Matsuda to EVP, Chief Legal Officer

ARQT

Mar 5, 9:06 AM

Arcutis first participant enrolled in Phase 1a/1b trial of ARQ-234-131

ARQT

Mar 3, 8:15 AM

Arcutis Biotherapeutics price target lowered by $2 at Mizuho, here's why

ARQT

Mar 2, 6:57 AM

Arcutis Biotherapeutics price target raised by $1 at Guggenheim, here's why

ARQT

Feb 27, 7:32 AM

Arcutis Biotherapeutics price target raised by $5 at TD Cowen, here's why

ARQT

Feb 26, 9:19 AM

Arcutis Biotherapeutics price target raised by $3 at Morgan Stanley, here's why

ARQT

Feb 26, 7:10 AM

Arcutis Biotherapeutics price target raised by $4 at H.C. Wainwright, here's why

ARQT

Feb 26, 6:04 AM

Arcutis Biotherapeutics files to sell common stock for holders, no amount given

ARQT

Feb 25, 4:33 PM

Arcutis Biotherapeutics files automatic mixed securities shelf

ARQT

Feb 25, 4:32 PM

Arcutis Biotherapeutics reports Q4 EPS 13c, consensus 9c

ARQT

Feb 25, 4:01 PM